Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers

American Journal of Epidemiology

Volumn 175, Issue 4, 2012, Pages 289-301

  Anderson, Laura N ^a,b   Cotterchio, Michelle ^a,b   Mirea, Lucia ^a,b   Ozcelik, Hilmi ^c   Kreiger, Nancy ^a,b  

^a Cancer Care Ontario ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

breast neoplasms; single nucleotide polymorphisms; tobacco smoke pollution

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2E1; DNA; EPHX1 PROTEIN; GLUCURONOSYLTRANSFERASE 1A7; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MANGANESE SUPEROXIDE DISMUTASE; NAT1 PROTEIN; NAT2 PROTEIN; PROTEIN; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

AGE; CANCER; GENE EXPRESSION; GENETIC ANALYSIS; GENOTYPE; HEALTH RISK; LOGISTICS; OCCUPATIONAL EXPOSURE; POLYMORPHISM; REGRESSION ANALYSIS; RISK FACTOR; SMOKE;

ADOLESCENCE; ADULT; ADULTHOOD; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER RISK; CARCINOGENESIS; CHILDHOOD; CONTROLLED STUDY; DNA DETERMINATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOME; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; PASSIVE SMOKING; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; SALIVA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL ENVIRONMENT; WORK ENVIRONMENT;

ADOLESCENT; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP2E1; FEMALE; GENETIC MARKERS; GENOTYPE; GENOTYPING TECHNIQUES; GLUCURONOSYLTRANSFERASE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; ONTARIO; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; TOBACCO SMOKE POLLUTION; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 84856734853     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr324     Document Type: Article

References (64)

1. Office of the Surgeon General, US Public Health Service. The Health Consequences of Smoking: A Report of the Surgeon General. Washington, DC: US Public Health Service; 2004.
2. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev. 2002;11(10):953-971. (Pubitemid 35192643)
3. Morabia A. Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001. EnvironMol Mutagen. 2002;39(2-3):89-95. (Pubitemid 34260480)
4. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002; 252(3):206-224.
5. Johnson KC. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer. 2005;117(4): 619-628. (Pubitemid 41504550)
6. Miller AB. Breast cancer and passive smoking. Prev Med. 2008; 46(6):497-498.
7. Lee PN, Hamling J. Environmental tobacco smoke exposure and risk of breast cancer in nonsmoking women: a review with meta-analyses. Inhal Toxicol. 2006;18(14):1053-1070. (Pubitemid 44581319)
8. Miller MD, Marty MA, Broadwin R, et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med. 2007;44(2):93-106. (Pubitemid 46188649)
9. Collishaw NE, Boyd NF, Cantor KP, et al. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Toronto, Ontario, Canada: Ontario Tobacco Research Unit; 2009.
10. International Agency for Research on Cancer, Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 83). Lyon, France: International Agency for Research on Cancer; 2004.
11. Office of the Surgeon General, US Public Health Service. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General.Washington, DC: US Public Health Service; 2006.
12. Pirie K, Beral V, Peto R, et al. Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol. 2008;37(5):1069-1079.
13. Terry PD, Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(4):602-611.
14. Alberg AJ, Daudt A, Huang HY, et al. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev. 2004;28(3):187-193. (Pubitemid 38836826)
15. Conlon MS, Johnson KC, Bewick MA, et al. Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiol. 2010;34(2):142-149.
16. Chang-Claude J, Kropp S, Jäger B, et al. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(8):698-704. (Pubitemid 34851902)
17. Delfino RJ, Smith C,West JG, et al. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics. 2000;10(5):461-469. (Pubitemid 30433579)
18. Lissowska J, Brinton LA, ZatonskiW, et al. Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer. 2006;119(8):1961- 1969. (Pubitemid 44356858)
19. Morabia A, Bernstein MS, Bouchardy I, et al. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol. 2000;152(3):226-232. (Pubitemid 30640245)
20. Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998;7(5):371-378. (Pubitemid 28354124)
21. Sillanpää P, Hirvonen A, Kataja V, et al. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer. 2005;114(4):579-584. (Pubitemid 40349616)
22. Sillanpää P, Heikinheimo L, Kataja V, et al. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population. Breast Cancer Res Treat. 2007;104(3):287-297. (Pubitemid 47231273)
23. Lilla C, Risch A, Kropp S, et al. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study. Breast Cancer Res. 2005;7(2): R229-R237.
24. Li Y, Millikan RC, Bell DA, et al. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res. 2004; 6(4):R460-R473.
25. MetsolaK,KatajaV, Sillanpää P, et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res. 2005;7(6):R987-R997.
26. Slattery ML, Curtin K, Giuliano AR, et al. Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat. 2008;109(1):101-111. (Pubitemid 351538759)
27. Anderson LN, Cotterchio M, Vieth R, et al. Vitamin D and calcium intakes and breast cancer risk in pre-and postmenopausal women. Am J Clin Nutr. 2010;91(6):1699-1707.
28. Cotterchio M, Boucher BA, Kreiger N, et al. Dietary phytoestrogen intake-lignans and isoflavones-and breast cancer risk (Canada). Cancer Causes Control. 2008;19(3):259-272.
29. Arand M, Mühlbauer R, Hengstler J, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem. 1996;236(1):184-186. (Pubitemid 26100747)
30. Maldonado G, Greenland S. Simulation study of confounderselection strategies. Am J Epidemiol. 1993;138(11):923-936.
31. Warnes G, Gorjanc G, Leisch F, et al. Genetics: Population Genetics. (R package, version 1.3.4). Vienna, Austria: R Foundation for Statistical Computing; 2008.
32. Reynolds P, Goldberg D, Hurley S, et al. Passive smoking and risk of breast cancer in the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3389-3398.
33. Wells AJ. Breast cancer, cigarette smoking, and passive smoking. Am J Epidemiol. 1991;133(2):208-210.
34. Smith SJ, Deacon JM, Chilvers CE. Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. Br J Cancer. 1994;70(1):112-119. (Pubitemid 24203637)
35. Morabia A, Bernstein M, Héritier S, et al. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol. 1996;143(9):918-928. (Pubitemid 26131099)
36. Lash TL, Aschengrau A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol. 1999; 149(1):5-12. (Pubitemid 29028856)
37. Johnson KC, Hu J, Mao Y. Passive and active smoking and breast cancer risk in Canada, 1994-97. Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control. 2000;11(3):211-221. (Pubitemid 30182138)
38. Liu L,Wu K, Lin X, et al. Passive smoking and other factors at different periods of life and breast cancer risk in Chinese women who have never smoked-a case-control study in Chongqing, People's Republic of China. Asian Pac J Cancer Prev. 2000;1(2):131-137.
39. Kropp S, Chang-Claude J. Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol. 2002;156(7):616-626.
40. Shrubsole MJ, Gao YT, Dai Q, et al. Passive smoking and breast cancer risk among non-smoking Chinese women. Int J Cancer. 2004;110(4):605-609. (Pubitemid 38658027)
41. Hanaoka T, Yamamoto S, Sobue T, et al. Active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer. 2005;114(2):317-322. (Pubitemid 40197517)
42. Gammon MD, Eng SM, Teitelbaum SL, et al. Environmental tobacco smoke and breast cancer incidence. Environ Res. 2004; 96(2):176-185. (Pubitemid 39119795)
43. Roddam AW, Pirie K, Pike MC, et al. Active and passive smoking and the risk of breast cancer in women aged 36-45 years: a population based case-control study in the UK. Br J Cancer. 2007;97(3):434-439. (Pubitemid 47196735)
44. Egan KM, Stampfer MJ, Hunter D, et al. Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology. 2002;13(2):138-145. (Pubitemid 34160487)
45. Reynolds P, Hurley S, Goldberg DE, et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst. 2004;96(1): 29-37. (Pubitemid 38180957)
46. Bonner MR, Nie J, Han D, et al. Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes Control. 2005;16(6):683-689. (Pubitemid 41110959)
47. Ahern TP, Lash TL, Egan KM, et al. Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control. 2009;20(10):1837-1844.
48. Lash TL, Aschengrau A. A null association between active or passive cigarette smoking and breast cancer risk. Breast Cancer Res Treat. 2002;75(2):181-184. (Pubitemid 34994954)
49. Ambrosone CB, Kropp S, Yang J, et al. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(1):15-26. (Pubitemid 351196269)
50. Lee KM, Park SK, Kim SU, et al. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett. 2003;196(2):179-186.
51. van der Hel OL, Bueno-de-Mesquita HB, van Gils CH, et al. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). Cancer Causes Control. 2005;16(6):675-681. (Pubitemid 41110958)
52. Ochs-Balcom HM, Wiesner G, Elston RC. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer. Am J Epidemiol. 2007;166(3):246-254. (Pubitemid 47216806)
53. Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122(2):459-469.
54. Chen C, Huang Y, Li Y, et al. Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis. J Hum Genet. 2007;52(5):423-435. (Pubitemid 46669306)
55. Masson LF, Sharp L, Cotton SC, et al. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161(10):901-915. (Pubitemid 40656412)
56. Saintot M, Malaveille C, Hautefeuille A, et al. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-O-methyltransferase and tobacco exposure in breast cancer risk. Int J Cancer. 2003; 107(4):652-657. (Pubitemid 37296129)
57. Glatt H, Engelke CE, Pabel U, et al. Sulfotransferases: genetics and role in toxicology. Toxicol Lett. 2000;112-113:341-348. (Pubitemid 30138142)
58. Wang Z, Fu Y, Tang C, et al. SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls. Breast Cancer Res Treat. 2010;122(1):193-198.
59. Jiang Y, Zhou L, Yan T, et al. Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of casecontrol studies with subgroups of ethnic and menopausal statue. J Exp Clin Cancer Res. 2010;29(1):101. (doi:10.1186/1756-9966-29-101).
60. Okasha M, McCarron P, Gunnell D, et al. Exposures in childhood, adolescence and early adulthood and breast cancer risk: a systematic review of the literature. Breast Cancer Res Treat. 2003;78(2):223-276. (Pubitemid 36433915)
61. Marcus PM, Newman B, Millikan RC, et al. The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control. 2000;11(3):271-278. (Pubitemid 30182144)
62. Morabia A, Bernstein M, Héritier S. Re: "Smoking and breast cancer: reconciling the epidemiologic evidence by accounting for passive smoking and/or genetic susceptibility" [letter]. Am J Epidemiol. 1998;147(10):992-993.
63. Bradbury BD, Wilk JB, Aschengrau A, et al. Departure from multiplicative interaction for catechol-O-methyltransferase genotype and active/passive exposure to tobacco smoke among women with breast cancer. J Carcinog. 2006;5(1):3. (doi:10.1186/1477-3163-5-3). (Pubitemid 43263154)
64. Marrett L, De P, Dryer D, et al. Canadian Cancer Statistics 2009. Toronto, Ontario, Canada: Canadian Cancer Society; 2009.